Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease

Published:2019-03-18 Issue:9 Volume:49 Page:1214-1222
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Buzzetti Elena¹^ORCID,Hall Andrew¹²^ORCID,Ekstedt Mattias³^ORCID,Manuguerra Roberta²^ORCID,Guerrero Misas Marta¹^ORCID,Covelli Claudia²^ORCID,Leandro Gioacchino⁴^ORCID,Luong TuVinh²^ORCID,Kechagias Stergios³^ORCID,Manesis Emanuel K.⁵^ORCID,Pinzani Massimo¹^ORCID,Dhillon Amar P.²^ORCID,Tsochatzis Emmanuel A.¹^ORCID

Affiliation:

1. UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL; London UK

2. Department of Cellular Pathology; Royal Free Hospital; London UK

3. Department of Medical and Health Sciences; Linköping University; Linköping Sweden

4. National Institute of Gastroenterology, “S. de Bellis” Research Hospital; Castellana Grotte Italy

5. Academic Department of Medicine; Hippokration General Hospital; Athens Greece

Funder

European Association for the Study of the Liver

AIGO (Associazione Italiana Gastroenterologi Ospedalieri) and M.I.M.I. (Montecatini Interactive Medicine International)

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15219/fullpdf

Reference33 articles.

1. Practice Guidelines for the management of non-alcoholic fatty liver disease;EASL-EASD-EASO Clinical;J Hepatol,2016

2. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey;Wong;Aliment Pharmacol Ther,2017

3. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD);Buzzetti;metabol,2016

4. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity;Ampuero;Aliment Pharmacol Ther,2018

5. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany;Labenz;Aliment Pharmacol Ther,2018

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. AI‐based digital pathology provides newer insights into lifestyle intervention‐induced fibrosis regression in MASLD: An exploratory study;Liver International;2024-07-04

3. Liver-Quant: Feature-Based Image Analysis Toolkit for Automatic Quantification of Metabolic Dysfunction-Associated Steatotic Liver Disease;2024-05-21

4. Non-invasive testing and risk-stratification in patients with MASLD;European Journal of Internal Medicine;2024-04

5. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15